Typically, patients who receive semaglutide have a body mass index (BMI) of 30 or above or a BMI of 27 or above with the presence of weight-related health conditions such as Type 2 diabetes, hypertension, or sleep apnea
Advisory roles with regulatory agencies (FDA, EMA, MHRA) and government bodies are disclosed for transparency but do not constitute conflicts of interest
NEWS IN PHOTOS: "Local" 4 NEWChrist Child Society Clothing Center helps families in need prepare for back to school 4 Shots fired during early morning home invasion in Granger, investigation underway 8 Plans underway to redevelop Benton Harbor's Riverfront 7 Don McLean performs "American Pie" at Goshen Theatre in new music series kickoff
Rudashevsky, NP Sep 2, 2025 9 min read Updated: Nov 17, 2025 Published by Medical Specialists MN | Reading Time: 8 minutes Key Takeaways What It Is: PT-141 (Bremelanotide) is a peptide therapy that works on the brain, not just blood vessels, to address both desire and physical arousal
others prefer the brand-name products